en
Scientific article
Comment
Open access
English

A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease

Published inNuclear Medicine Communications, vol. 41, no. 9, p. 837-840
Publication date2020
Citation (ISO format)
SHIRI LORD, Isaac et al. A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease. In: Nuclear Medicine Communications, 2020, vol. 41, n° 9, p. 837–840. doi: 10.1097/MNM.0000000000001269
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0143-3636
248views
194downloads

Technical informations

Creation08/14/2020 11:02:00 AM
First validation08/14/2020 11:02:00 AM
Update time03/15/2023 10:43:06 PM
Status update03/15/2023 10:43:05 PM
Last indexation05/05/2024 5:16:52 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack